Pharmacist-led medication therapy management: Impact on healthcare utilization and costs

The implementation of pharmacist-led medication therapy management (MTM) has emerged as a pivotal strategy in modern healthcare, demonstrating considerable potential to revolutionize patient care, healthcare utilization, and cost-effectiveness. Pharmacist-led MTM is a patient-centric approach, utilizing pharmacists’ expertise to optimize medication usage and enhance patient outcomes. Through meticulous medication reviews, personalized medication plans, and continuous patient engagement, MTM addresses medication-related issues, tailors care strategies, and ensures adherence, resulting in improved therapeutic outcomes and reduced healthcare utilization and costs. Studies across diverse healthcare domains consistently illustrate the tangible benefits of pharmacist-led MTM. Reported outcomes include marked reductions in hospital visits, hospital readmissions due to medication-related issues, and substantial enhancements in medication adherence rates. Notably, in chronic conditions such as diabetes and cardiovascular diseases, pharmacist-led interventions not only improve clinical outcomes but also exhibit a positive return on investment for employers, underlining its cost-saving potential. Pharmacist-led interventions in human immunodeficiency virus management, hypertension, and other chronic diseases have demonstrated significant clinical improvements, including reduced hospitalizations and improved patient adherence to medication use. By actively addressing medication-related challenges, providing patient education, and ensuring medication adherence, pharmacists play a pivotal role in optimizing healthcare utilization and cost-effectiveness. The integration of MTM into chronic disease management and transitional care pathways emphasizes its transformative capacity in healthcare delivery. Pharmacist-led MTM consistently demonstrates its ability to mitigate drug-related problems, minimize unnecessary medication use, and enhance overall patient care, offering a promising avenue toward improved healthcare outcomes and cost savings.

Authors

Institutions

Publication Details

Journal
American Journal of Pharmacotherapy and Pharmaceutical Sciences
Published
2025-02-15
DOI
https://doi.org/10.25259/ajpps_2025_004
Citations
6
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
7.34
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacist-led medication therapy management: Impact on healthcare utilization and costs

Abdulmuminu Isah, Chukwuemeka Augustine Nwachuya, Anthony Uche Umeh, Uzochukwu Emmanuel Chima et al.
6 citations
American Journal of Pharmacotherapy and Pharmaceutical Sciences
Pharmaceutical Practices and Patient Outcomes
7.34
article

Pharmacist-led medication therapy management: Impact on healthcare utilization and costs

Abdulmuminu Isah, Chukwuemeka Augustine Nwachuya, Anthony Uche Umeh, Uzochukwu Emmanuel Chima, Somadina Sixtus Mmuo, Onyeka Stephanie Chiekwe, Chinonyelum Emmanuel Agbo, Amarachi Esther Eze, Chiamaka Emmanuella Nnedu
article en
6 citations

Abstract

The implementation of pharmacist-led medication therapy management (MTM) has emerged as a pivotal strategy in modern healthcare, demonstrating considerable potential to revolutionize patient care, healthcare utilization, and cost-effectiveness. Pharmacist-led MTM is a patient-centric approach, utilizing pharmacists’ expertise to optimize medication usage and enhance patient outcomes. Through meticulous medication reviews, personalized medication plans, and continuous patient engagement, MTM addresses medication-related issues, tailors care strategies, and ensures adherence, resulting in improved therapeutic outcomes and reduced healthcare utilization and costs. Studies across diverse healthcare domains consistently illustrate the tangible benefits of pharmacist-led MTM. Reported outcomes include marked reductions in hospital visits, hospital readmissions due to medication-related issues, and substantial enhancements in medication adherence rates. Notably, in chronic conditions such as diabetes and cardiovascular diseases, pharmacist-led interventions not only improve clinical outcomes but also exhibit a positive return on investment for employers, underlining its cost-saving potential. Pharmacist-led interventions in human immunodeficiency virus management, hypertension, and other chronic diseases have demonstrated significant clinical improvements, including reduced hospitalizations and improved patient adherence to medication use. By actively addressing medication-related challenges, providing patient education, and ensuring medication adherence, pharmacists play a pivotal role in optimizing healthcare utilization and cost-effectiveness. The integration of MTM into chronic disease management and transitional care pathways emphasizes its transformative capacity in healthcare delivery. Pharmacist-led MTM consistently demonstrates its ability to mitigate drug-related problems, minimize unnecessary medication use, and enhance overall patient care, offering a promising avenue toward improved healthcare outcomes and cost savings.

American Journal of Pharmacotherapy and Pharmaceutical SciencesVol. 4
University of Nigeria (NG)
Openalex Percentile: Top 3%
Pharmaceutical Practices and Patient Outcomes
7.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.